Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel anticoagulant presented by Ajinomoto at Japanese Pharmacological Society meeting

April 3, 2000

Novel antiplatelet agents in the Searle pipeline

April 3, 2000

Highly potent and orally bioavailable nonbenzamidine factor Xa inhibitors presented to ACS

March 29, 2000

3-Dimensional Pharmaceuticals begins clinical testing of oral thrombin inhibitor

March 29, 2000

Nonpeptide protease inhibitors designed and evaluated at 3-D

March 28, 2000

CPMP recommends approval of Kogenate Bayer as hemophilia A treatment

March 27, 2000

Orally bioavailable gpIIb/IIIa receptor antagonist ME-3230 profiled at Japanese meeting

March 27, 2000

Na/Ca2+ exchange inhibitor KB-R7943 evaluated for effects on platelet aggregation

March 24, 2000

Functional studies confirm potent 5-HT2A-antagonist activity of AT-1015

March 24, 2000

Genentech outlines clinical trial plan for TNKase in combination with leading antithrombotics

March 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...